Tyenne 20 mg/mL concentrate for solution for infusion
*Company:
Fresenius Kabi LtdStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
File name
Tyenne Dosing Guide IRELAND 2024 Update.pdf
Reasons for updating
- Replace File
File name
Tyenne Patient Brochure IRELAND (1).pdf
Reasons for updating
- Replace File
File name
Tyenne Patient Alert Card IRELAND COMPACT.pdf
Reasons for updating
- Replace File
File name
Tyenne Healthcare Professional Brochure IRELAND (2).pdf
Reasons for updating
- Add New Doc
File name
Tyenne Dosing Guide IRELAND.pdf
Reasons for updating
- Add New Doc
File name
Tyenne Patient Brochure IRELAND (1).pdf
Reasons for updating
- Add New Doc
File name
Tyenne Patient Alert Card IRELAND COMPACT.pdf
Reasons for updating
- Add New Doc
Updated on 01 November 2023
File name
IE-SmPC-tyenne-Vial-v001.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 November 2023
File name
PIL Vial.pdf
Reasons for updating
- New PIL for new product
Fresenius Kabi Ltd
Address:
Unit 3B Fingal Bay Business Park, Balbriggan, Co. Dublin, Ireland, K32YK12Medical Information E-mail:
Medical.Information-uk@fresenius-kabi.com , jeremy.morais@fresenius-kabi.comTelephone:
+353 01 8413030 0Website:
www.fresenius-kabi.com/ieMedical Information Facsimile:
+ 353 1 849 6949Medical Information Direct Line:
+ 353 1 841 3030 , +44 1928 533575Stock Availability:
FK-enquiries.Ireland@fresenius-kabi.com